Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Replacement Stratified by TRISCEND II Trial Eligibility.

J Soc Cardiovasc Angiogr Interv · 2026 · PMC13154619 · PMID 42111092

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

did not reach statistical significanceP = .11not close (p > 0.1)

Although prior heart failure hospitalization in the past 12 months was more frequent among noneligible patients compared to eligible patients (13.8% vs 4.3%), this difference did not reach statistical significance ( P = .11).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.